Bariatrics/GI- AbbVie

Status:

Enrolling by invitation

ClinicalTrials.gov:

NCT03345823

AbbVie_M14-430_

Drug

Upadacitinib/Placebo for Upadacitinib

Phase

III

Condition

Chron's Disease